First Week of October 18th Options Trading For Array BioPharma (ARRY)

Investors in Array BioPharma Inc. ( ARRY) saw new options become available this week, for the October 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARRY options chain for the new October 18th contracts and identified the following call contract of particular interest.

The call contract at the $4.00 strike price has a current bid of 30 cents. If an investor was to purchase shares of ARRY stock at the current price level of $3.95/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $4.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 8.86% if the stock gets called away at the October 18th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if ARRY shares really soar, which is why looking at the trailing twelve month trading history for Array BioPharma Inc., as well as studying the business fundamentals becomes important. Below is a chart showing ARRY's trailing twelve month trading history, with the $4.00 strike highlighted in red:

Loading+chart++2014+TickerTech.com

Considering the fact that the $4.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 46%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 7.59% boost of extra return to the investor, or 46.20% annualized, which we refer to as the YieldBoost.

START SLIDESHOW:
Top YieldBoost Calls of the S&P 500 »

The implied volatility in the call contract example above is 74%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $3.95) to be 55%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.

If you liked this article you might like

STMicroelectronics, Intercept Pharmaceuticals: 'Mad Money' Lightning Round

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

Mirati Skyrockets On Positive Data - Biotech Movers

Array BioPharma Seems to Be in a New Uptrend